Method Article
Hemorrhagic shock is a severe complication in seriously injured patients, which leads to life-threatening oxygen undersupply. We present a standardized method to induce hemorrhagic shock via blood withdrawal in pigs that is guided by hemodynamics and microcirculatory cerebral oxygenation.
Hemorrhagic shock ranks among the main reasons for severe injury-related death. The loss of circulatory volume and oxygen carriers can lead to an insufficient oxygen supply and irreversible organ failure. The brain exerts only limited compensation capacities and is particularly at high risk of severe hypoxic damage.This article demonstrates the reproducible induction of life-threatening hemorrhagic shock in a porcine model by means of calculated blood withdrawal. We titrate shock induction guided by near-infrared spectroscopyĀ and extended hemodynamic monitoring to display systemic circulatory failure, as well as cerebral microcirculatory oxygen depletion. In comparison to similar models that primarily focus on predefined removal volumes for shock induction, this approach highlights a titration by means of the resulting failure of macro- and microcirculation.
Massive blood loss is among the main causes of injury-related deaths1,2,3. The loss of circulatory fluid and oxygen carriers leads to hemodynamic failure and severe oxygen undersupply and can cause irreversible organ failure and death. The severity level of shock is influenced by additional factors like hypothermia, coagulopathy, and acidosis4. Particularly the brain, but also the kidneys lack compensation capacity due to high oxygen demand and the incapability of adequate anaerobic energy generation5,6. For therapeutic purposes, fast and immediate action is pivotal. In clinical practice, fluid resuscitation with a balanced electrolyte solution is the first option for treatment, followed by the administration of red blood cell concentrates and fresh frozen plasma. Thrombocyte concentrates, catecholamines, and the optimization of coagulation and the acid-base status support the therapy to regain normal physiological conditions after sustained trauma. This concept focuses on the restoration of hemodynamics and macrocirculation. Several studies, however, show that microcirculatory perfusion does not recover simultaneously with the macrocirculation. Especially, cerebral perfusion remains impaired and further oxygen undersupply may occur7,8.
The use of animal models allows scientists to establish novel or experimental strategies. The comparable anatomy, homology, and physiology of pigs and humans enable conclusions on specific pathological factors. Both species have a similar metabolic system and response to pharmacologic treatments. This is a great advantage in comparison to small animalĀ models where differences in blood volume, hemodynamics, and overall physiology make it almost impossible to mimic a clinical scenario9. Furthermore, authorized medical equipment and consumables can be easily used in porcine models. Additionally, it is easily possible to obtain pigs from commercial suppliers, which allows a high diversity of genetics and phenotypes and is cost reducing10. The model of blood withdrawal via vessel cannulation is quite common11,12,13,14,15.
In this study, we extend the concept of hemorrhagic shock induction via arterial blood withdrawal with an exact titration of hemodynamic failure and cerebral oxygenation impairment. Hemorrhagic shock is achieved if the cardiac index and mean arterial pressure drops below 40% of the baseline value, which has been shown to cause considerable deterioration of the cerebral regional oxygenation saturation8. Pulse contour cardiac output (PiCCO) measurement is used for continuous hemodynamic monitoring. First, the system has to be calibrated by transpulmonary thermodilution, which enables the calculation of the cardiac index of the extravascular lung water content and the global end-diastolic volume. Subsequently, the continuous cardiac index is calculated by pulse contour analysis and also provides dynamic preload parameters like pulse pressure and stroke volume variation.
This technique is well established in clinical and experimental settings.Near-infrared spectroscopy (NIRS) is a clinically and experimentally established method to monitor changes in cerebral oxygen supply in real-time. Self-adherent sensors are attached to the left and right forehead and calculate the cerebral oxygenation non-invasively in the cerebral frontal cortex. Two wavelengths of infrared light (700 and 900 nm) are emitted and detected by the sensors after being reflected from the cortex tissue. To assess the cerebral oxygen content, contributions of arterial and venous blood are calculated in 1:3 relations and updated in 5 s intervals. The sensitivity in depth of 1-4 cm is exponential decreasing and influenced by the penetrated tissue (e.g., skin and bone), although the skull is translucent to infrared light. The technique facilitates quick therapeutic actions to prevent patients from adverse outcomes like delirium or hypoxic cerebral injury and serves as the target parameter in case of impaired cardiac output16,17. The combination of both techniques during experimental shock enables an exact titration of macrocirculation, as well as cerebral microcirculatory impairment, to study this life-threatening event.
The experiments in this protocol were approved by the State and Institutional Animal Care Committee (Landesuntersuchungsamt Rheinland-Pfalz, Koblenz, Germany; Chairperson: Dr. Silvia Eisch-Wolf; reference number: 23 177-07/G 14-1-084; 02.02.2015). The experiments were conducted in accordance with the Animal Research Reporting of In Vivo Experiments (ARRIVE) guidelines. The study was planned and conducted between November 2015 and March 2016. After extended literature research, the pig model was chosen as a well-established model for hemorrhagic shock. Seven anesthetized male pigs (Sus scrofa domestica) with a mean weight of 28 ± 2 kg and an age of 2-3 months were included in the protocol. The animals were cared for by a local breeder that was recommended by the State and Institutional Animal Care Committee. The animals were kept in their known environment as long as possible to minimize stress. Food, but not water was denied 6 h before the experiment was scheduled, to reduce the risk of aspiration. The representative time course is displayed in Figure 1.
1. Anesthesia, Intubation, and Mechanical Ventilation
2. Instrumentation
3. PiCCO Measurement
NOTE: For the PiCCO equipment, see the Table of Materials.
4. Cerebral Regional Oxygenation Saturation
NOTE: For the equipment to monitor cerebral regional oxygenation, see the Table of Materials.
5. Hemorrhagic Shock Induction
6. End of the Experiment and Euthanasia
After starting the shock induction, a short time of compensation can be registered. With ongoing blood removal, the aforementioned cardio-circulatory decompensation, as monitored by a significant decrease of crSO2, the cardiac index, the intrathoracic blood volume index, and the global end-diastolic volume index (Figure 2, Figure 3, and Figure 4), occurs. Furthermore, significant tachycardia and a decrease of arterial blood pressure are observed as common manifestations of hemorrhagic shock (Figure 2). Stroke volume variation increases significantly (Figure 3). Extravascular lung water content and systemic vascular resistance are usually unaffected (Figure 3). After ending the blood withdrawal (28 ± 2 mL·kg-1), the hemodynamic values remain on a critically low level. Parallelly, crSO2 also drops down significantly. These sensors do not regularly start on the same level, but the percental dropdown is comparable. Figure 4 shows a representative recording from one animal. Hemoglobin content and hematocrit do not directly decrease in the process, but lactate levels rise and the central venous oxygen saturation decreases (Figure 5).
Figure 1: Experimental flow chart. The baseline is set after preparation and a 30 min stabilization. Shock is induced for 30 min. Pulse contour cardiac output parameters and cerebral regional oxygenation are measured during the whole experiment. The times of measurement are termed as Preparation, Baseline, and Shock.Ā
Figure 2: Development of hemodynamics during hemorrhagic shock.Ā Effects over time are analyzed by ANOVA and post hoc Student-Newman-Keuls method. #p < 0.05 to baseline. Data are presented as mean and standard deviation. (A) Heart rate (B) mean arterial pressure, and (C) central venous pressure are considerably influenced in this model. Please click here to view a larger version of this figure.
Figure 3: Development of the pulse contour cardiac output and thermodilution-derived parameters during hemorrhagic shock.Ā Effects over time are analyzed by ANOVA and post hoc Student-Newman-Keuls method. #p < 0.05 to baseline. Data are presented as mean and standard deviation. (A) Cardiac index decreases, (B) Stroke volume variation increases, (D) intrathoracic blood volume index and (E) global end-diastolic volume index decrease, (C) systemic vascular resistance index and (F) extravascular lung water index remain unaffected. Please click here to view a larger version of this figure.
Figure 4: crSO2 flow chartĀ during hemorrhagic shock in one representative animal. The left panel shows a schematic presentation of the crSO2 during hemorrhagic shock. The right panel shows the display of the NIRS system. crSO2 significantly breaks down through shock induction and remains at a low level after the blood withdrawal is ended.Ā
Figure 5: Development of hematologic parameters during hemorrhagic shock. Effects over time are analyzed by ANOVA and post hoc Student-Newman-Keuls method. #p < 0.05 to baseline. Data are presented as mean and standard deviation. (A) Hemoglobin and (D) base excess remain unaffected, (C) lactate level rises significantly, (B) central venous oxygen saturation decreases.Ā Please click here to view a larger version of this figure.
The protocol describes one method of inducing hemorrhagic shock via controlled arterial bleeding in pigs that is guided by systemic hemodynamics, as well as by cerebral microcirculatory impairment. Shock conditions were achieved by a calculated blood withdrawal of 25-35 mL kg-1 and confirmed by the mentioned composite of surrogate parameters indicating considerable cardio-circulatory failure. If untreated, this procedure was lethal within 2 h in 66% of the animals, which underlines the severity and reproducibility of the model. Adequate fluid resuscitation, on the other hand, restabilized the circulation and approved the patency to mimic a clinical scenario8. However, less blood loss may not lead to the hemodynamic instability that also affected crSO2 leading to experimental failure. The amount of removed blood needsĀ to be adapted to the animal's body weight, which corresponded with the total blood volume8.
This method allows scientists to examine different aspects of this life-threatening condition and opens up the opportunity to study a wide array of therapeutic interventions in a pseudoclinical scenario. In this context, it is important to note that during manifest hemorrhagic shockĀ the macrocirculation alone hardly indicates an intact or impaired microcirculation and organ oxygen supply7. The advantage of the procedure lies in its simple design and usability. The transfer to other medium-sized mammals appears uncomplicated, although different species may exhibit specific challenges. The design provides high flexibility as different levels of cardio-circulatory impairment can be easily chosen by titrating the effect variables. The combination with NIRS provides information about the otherwise unrecognized microcirculatory oxygen supply during hemorrhagic shock.
Some of the model's critical steps have to be highlighted and require attention. Adequate sedation prior to transport is essential to avoid stress that could complicate the animal handling and falsify results by endogenic catecholamine release. The porcine snout, with its long oropharyngeal cavity, complicates intubation and makes the assistance of a second person reasonable. Regularly, the epiglottis sticks to the palate and has to be mobilized with the tip of the tube. The narrowest part of the airway is not at the level of the vocal cords but subglottic, like in pediatric patients23. These aspects make adequate muscle relaxation essential because intubation is facilitated. Ultrasound-guided vessel catheterization is preferable, although surgical access can also be used in reproducible fashion. The minimally invasive technique needs special training and experience but can minimize uncontrolled bleeding, tissue damage, complication rates, access time, and pain24. The induction of the hemorrhagic shock itself appears to be very simple, but the user should be aware of several pitfalls. It is important to reduce the blood removal speed to recognize hemodynamic instability. Arterial removal is efficient, but when it is performed too fast, it can lead to unplanned cardio-circulatory and experimental failure. The calculation of the approximate extraction volume helps to manage the removal and avoids critically low cardio-circulatory levels25,26,27. Other published protocols vary in terms of targeted hemodynamic failure, amount of removed blood volume, and period of blood withdrawal. The punctuated vessel can differ as well27,28.
NIRS enables real-time measurements of the crSO2. In several clinical settings, this method has been used to recognize an impaired cerebral oxygen supply: particularly during cardiac and major vascular surgery, NIRS represents a valuable tool. NIRS-derived parameters can predict a worse neurological outcome and patient survival caused by insufficient tissue oxygenation29. Interestingly, the intracerebral lactate level decreases in correlation with the NIRS values. Studies have shown that during oxidative stress lactate can be utilized as a source of pyruvate, and the intracranial lactate level decreases10. These findings and measurements are not considered in this basic model description. Changes of mean arterial pressure that influence the cerebral perfusion, PaO2, PaCO2, or the hemoglobin directly affect NIRS-derived crSO230,31. NIRS has a prognostic value in patients suffering from hemorrhagic shock and hemodynamic instability as well32,33,34,35,36,37,38,39. However, several limitations and disadvantages have to be noted. Extracranial tissue below the sensors, like skin, muscles, and fat, may influence the measurements and can lead to false negative results. The spatial resolution is low, and the penetration depth is limited32,33,34,40,41,42,43. The method neither differentiates between arterial and venous blood nor between oxygen delivery and demand41,44,45. The device is primarily approved for human application. The used sensors are designed for human adults. Smaller sensors for children and newborns exist, but these were not available for this protocol. In pigs, the technique is widely accepted, and crSO2 correlates with a partial pressure of oxygen, quantitative electroencephalography, and cerebral venous oxygen saturation46,47. Several devices directly measure the oxygen partial pressure in the cerebral tissue. For this purpose, the probes have to be inserted surgically into the brain. This enables unaffected measurements in the respective region of interest and avoids disturbances by surrounding noncerebral tissue. This approach is highly invasive and rather suitable for special scenarios like neurosurgical procedures48,49,50,51. The use of porcine models to simulate human pathomechanisms is a very common approach11,12,13,15. The advantage lies in the physiologic comparability between both species. Experiments that simulate life-threatening clinical conditions require fundamental expertise in intensive care medicine and anesthesia but also in specific species-related features. This allows mimicking clinical scenarios in realistic fashion for the translational testing of novel devices or therapeutic regimes on the threshold to clinical application8,52. However, we have to be aware that direct or immediate conclusions concerning clinical application can hardly be drawn from experimental models. Some relevant differences and limitations have to be noted: regarding shock or hemorrhage, the porcine coagulation system appears to be more effective and the hemoglobin content is significantly lower. Also, lactate and succinate plasma levels differ53. The porcine blood consists of an "A0" blood group system, compared to the human "AB0" system54. Some studies discuss if splenectomy should be performed to exclude the occurrence of intrinsic autotransfusion in porcine shock models. On the other hand, during splenectomy, oxidative stress, pain, and sympathetic stimulation occur, and the procedure is associated with autotransfusion reactions by itself. For these reasons, splenectomy is not recommended55,56. The use of clinically approved devices has some systemic sources of error. The PiCCO system requires calculation of the body surface area, which differs between pigs and humans. This can cause a systemic error, but the trending ability of the device will be unaffected. Other methods of cardiac output measurement, like echocardiography or a pulmonary arterial catheter, can be discussed in this setting.
In conclusion, this protocol presents a standardized hemorrhagic shock model initiated by arterial blood withdrawal and controlled by extended hemodynamic monitoring, as well as crSO2. In comparison to similar models that primarily focus on predefined removal volumes for shock induction, this approach highlights a titration by means of the resulting failure of macro- and microcirculation.
The NIRS device was provided unconditionally by Medtronic PLC, USA, for experimental research purposes. Alexander Ziebart, Andreas Garcia-Bardon, and Erik K. Hartmann received instructor honoraria for physician training courses from Medtronic PLC. None of the authors report financial or other conflicts of interest.
The authors want to thank Dagmar Dirvonskis for her excellent technical support.
Name | Company | Catalog Number | Comments |
3-way-stopcock blue | Becton Dickinson Infusion Therapy AB Helsingborg, Sweden | 394602 | Drug administration |
3-way-stopcock red | Becton Dickinson Infusion Therapy AB Helsingborg, Sweden | 394605 | Drug administration/Shock induction |
Atracurium | Hikma Pharma GmbH , Martinsried | AM03AC04* | Anesthesia |
Canula 20 G | Becton Dickinson S.A. Carretera Mequinenza Fraga, Spain | 301300 | Vascular access |
Datex Ohmeda S5 | GE Healthcare Finland Oy, Helsinki, Finland | - | Hemodynamic monitor |
Desinfection | Schülke & Mayr GmbH, Germany | 104802 | Desinfection |
Heidelberger Verlängerung 75CM | Fresenius Kabi Deutschland GmbH | 2873112  | Drug administration/Shock induction |
INVOS 5100C Cerebral | Medtronic PLC, USA | - | Monitore for cerebral regional oxygenationĀ |
INVOS Cerebral/Somatic Oximetry Adult Sensors | Medtronic PLC, USA | 20884521211152 | Monitoring of the cerebral regional oxygenationĀ |
Endotracheal tube | Teleflex Medical Sdn. Bhd, Malaysia | 112482 | Intubation |
Endotracheal tube introducer | Ā Wirutec GmbH, Sulzbach, Germany | 5033062 | Intubation |
Engstrƶm Carestation | GE Heathcare, Madison USA | - | Ventilator |
Fentanyl | Janssen-Cilag GmbH, Neuss | AA0014* | Anesthesia |
Gloves | Paul Hartmann, Heidenheim, Germany | 9422131 | Self-protection |
Incetomat-line 150 cm | Fresenius, Kabi GmbH, Bad Homburg, Germany | 9004112 | Drug administration |
Ketamine | Hameln Pharmaceuticals GmbH, Zofingen, Schweiz | AN01AX03* | Sedation |
Laryngoscope | Teleflex Medical Sdn. Bhd, Malaysia | 671067-000020 | Intubation |
Logical pressure monitoring system | Smith- Medical GmbH,Ā Minneapolis, USA | MX9606 | Hemodynamic monitor |
Logicath 7 Fr 3-lumen 30cm | Smith- Medical GmbH,Ā Minneapolis, USA | MXA233x30x70-E | Vascular access/Drug administration |
Masimo Radical 7 | Masimo Corporation, Irvine, USA | - | Hemodynamic monitor |
Mask for ventilating dogs | Henry Schein, Melville, USA | 730-246 | Ventilation |
Original Perfusor syringe 50ml Luer Lock | B.Braun Melsungen AG, Melsungen, Germany | 8728810F | Drug administration |
PICCO Thermodilution. F5/20CM EWĀ | MAQUET Cardiovascular GmbH, Rastatt, Germany | PV2015L20-A Ā | Hemodynamic monitor |
Percutaneous sheath introducer set 8,5 und 9 Fr, 10 cm with integral haemostasis valve/sideport | Arrow international inc., Reading, USA | AK-07903 | Vascular access/Shock induction |
Perfusor FM Braun | B.Braun Melsungen AG, Melsungen, Germany | 8713820 | Drug administration |
Potassium chloride | Fresenius, Kabi GmbH, Bad Homburg, Germany | 6178549 | Euthanasia |
Propofol 2% | Fresenius, Kabi GmbH, Bad Homburg, Germany | Ā AN01AX10* | Anesthesia |
Ā Pulse Contour Cardiac Output (PiCCO2)Ā | Pulsion Medical Systems, Feldkirchen, Germany | - | Hemodynamic monitor |
Sonosite Micromaxx Ultrasoundsystem | Fujifilm, Sonosite Bothell, Bothell, USAĀ | - | Vascular access |
Stainless Macintosh Size 4 | Teleflex Medical Sdn. Bhd, Perak,Ā Malaysia | 670000 | Intubation |
Sterofundin | B.Braun Melsungen AG, Melsungen, Germany | AB05BB01* | balanced electrolyte infusion |
Stresnil 40mg/mlĀ Ā | Lilly Germany GmbH, Wiesbaden, Germany | QN05AD90 | Sedation |
Syringe 10 mL | Becton Dickinson S.A. Carretera Mequinenza Fraga, Spain | 309110 | Drug administration |
Syringe 2 mL | Becton Dickinson S.A. Carretera Mequinenza Fraga, Spain | 300928 | Drug administration |
Syringe 20 mL | Becton Dickinson S.A. Carretera Mequinenza Fraga, Spain | 300296 | Drug administration |
Syringe 5 mL | Becton Dickinson S.A. Carretera Mequinenza Fraga, Spain | 309050 | Drug administration |
venous catheter 22G | B.Braun Melsungen AG, Melsungen, Germany | 4269110S-01 | Vascular access |
*ATC:Ā Anatomical Therapeutic Chemical / Defined Daily Dose ClassificationĀ |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright Ā© 2025 MyJoVE Corporation. All rights reserved